Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

10% owner at Boundless Bio, Inc. · on record since Mar 27, 2024
10% owner at Artiva Biotherapeutics, Inc. · on record since Jul 22, 2024
10% owner at Zenas BioPharma, Inc. · on record since Sep 18, 2024
10% owner at Verve Therapeutics, Inc. · on record since Jun 22, 2021
10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
10% owner at Forma Therapeutics Holdings, Inc. · on record since Jun 25, 2020
10% owner at Generation Bio Co. · on record since Jun 18, 2020
10% owner at Nurix Therapeutics, Inc. · on record since Jul 30, 2020
Former 10% Owner at PMV Pharmaceuticals, Inc. · on record since Sep 29, 2020
10% owner at Kymera Therapeutics, Inc. · on record since Aug 27, 2020
10% owner at Olema Pharmaceuticals, Inc. · on record since Nov 24, 2020
10% owner at Aligos Therapeutics, Inc. · on record since Oct 22, 2020
10% owner at Edgewise Therapeutics, Inc. · on record since Mar 30, 2021
10% owner at Nuvalent, Inc. · on record since Jul 28, 2021
10% owner at Acrivon Therapeutics, Inc. · on record since Nov 21, 2022
10% owner at Dyne Therapeutics, Inc. · on record since Sep 23, 2020

Insider trading activity of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Transactions on record: 47; since Feb 5, 2020

Open-market buys: 2; $40.9M

Open-market sells: 0

Companies traded: 16; last filing Sep 18, 2024

Figures computed from official regulatory filings — .

Companies where Wellington Biomedical Innovation Master Investors (Cayman) I L.P. has traded

6 tx · Sep 18, 2024
3 tx · $500K · Jul 22, 2024
4 tx · Apr 2, 2024
2 tx · Nov 21, 2022
2 tx · Aug 3, 2021
4 tx · Jun 22, 2021
2 tx · Mar 30, 2021
4 tx · Nov 24, 2020
4 tx · Oct 22, 2020
2 tx · Sep 29, 2020
2 tx · Sep 23, 2020
2 tx · Aug 27, 2020
2 tx · Jul 30, 2020
3 tx · $20M · Jun 25, 2020
3 tx · $20.9M · Jun 18, 2020
2 tx · Feb 5, 2020

Track record of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Co-insiders of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	Other	200,718	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	Other	180,635	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-3,649,263	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	Other	420,271	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-1,742,858	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-1,568,480	—	n/a (No price was disclosed in the filing)	SEC
Artiva Biotherapeutics, Inc.Listing unverified	Jul 22, 2024	OtherD (derivative)	-145,089	—	n/a (No price was disclosed in the filing)	SEC
Artiva Biotherapeutics, Inc.Listing unverified	Jul 22, 2024	Other	145,089	—	n/a (No price was disclosed in the filing)	SEC
Artiva Biotherapeutics, Inc.Listing unverified	Jul 22, 2024	Other	49,019	10.20 USD	$500K	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	OtherD (derivative)	-7,142,857	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	Other	189,933	—	n/a (No price was disclosed in the filing)	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	Other	366,300	—	n/a (No price was disclosed in the filing)	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	OtherD (derivative)	-3,703,704	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acrivon Therapeutics, Inc.Listing on record	Nov 21, 2022	Other	888,130	—	n/a (No price was disclosed in the filing)	SEC
Acrivon Therapeutics, Inc.Listing on record	Nov 21, 2022	OtherD (derivative)	-2,190,131	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nuvalent, Inc.Security delisted	Aug 3, 2021	Other	897,671	—	n/a (No price was disclosed in the filing)	SEC
Nuvalent, Inc.Security delisted	Aug 3, 2021	OtherD (derivative)	-4,831,384	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	OtherD (derivative)	-12,436,264	—	n/a (No price was disclosed in the filing)	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	Other	1,343,081	—	n/a (No price was disclosed in the filing)	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	OtherD (derivative)	-10,671,482	—	n/a (No price was disclosed in the filing)	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	Other	1,152,490	—	n/a (No price was disclosed in the filing)	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	681,812	—	n/a (No price was disclosed in the filing)	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-681,812	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Olema Pharmaceuticals, Inc.Listing on record	Nov 24, 2020	Other	1,273,420	—	n/a (No price was disclosed in the filing)	SEC
Olema Pharmaceuticals, Inc.Listing on record	Nov 24, 2020	OtherD (derivative)	-451,986	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	Other	200,718	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	Other	180,635	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-3,649,263	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	Other	420,271	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-1,742,858	—	n/a (No price was disclosed in the filing)	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-1,568,480	—	n/a (No price was disclosed in the filing)	SEC
Artiva Biotherapeutics, Inc.Listing unverified	Jul 22, 2024	OtherD (derivative)	-145,089	—	n/a (No price was disclosed in the filing)	SEC
Artiva Biotherapeutics, Inc.Listing unverified	Jul 22, 2024	Other	145,089	—	n/a (No price was disclosed in the filing)	SEC
Artiva Biotherapeutics, Inc.Listing unverified	Jul 22, 2024	Other	49,019	10.20 USD	$500K	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	OtherD (derivative)	-7,142,857	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	Other	189,933	—	n/a (No price was disclosed in the filing)	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	Other	366,300	—	n/a (No price was disclosed in the filing)	SEC
Boundless Bio, Inc.Listing on record	Apr 2, 2024	OtherD (derivative)	-3,703,704	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Acrivon Therapeutics, Inc.Listing on record	Nov 21, 2022	Other	888,130	—	n/a (No price was disclosed in the filing)	SEC
Acrivon Therapeutics, Inc.Listing on record	Nov 21, 2022	OtherD (derivative)	-2,190,131	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Nuvalent, Inc.Security delisted	Aug 3, 2021	Other	897,671	—	n/a (No price was disclosed in the filing)	SEC
Nuvalent, Inc.Security delisted	Aug 3, 2021	OtherD (derivative)	-4,831,384	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	OtherD (derivative)	-12,436,264	—	n/a (No price was disclosed in the filing)	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	Other	1,343,081	—	n/a (No price was disclosed in the filing)	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	OtherD (derivative)	-10,671,482	—	n/a (No price was disclosed in the filing)	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 22, 2021	Other	1,152,490	—	n/a (No price was disclosed in the filing)	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	Other	681,812	—	n/a (No price was disclosed in the filing)	SEC
Edgewise Therapeutics, Inc.Listing on record	Mar 30, 2021	OtherD (derivative)	-681,812	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Olema Pharmaceuticals, Inc.Listing on record	Nov 24, 2020	Other	1,273,420	—	n/a (No price was disclosed in the filing)	SEC
Olema Pharmaceuticals, Inc.Listing on record	Nov 24, 2020	OtherD (derivative)	-451,986	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC